Voyager Therapeutics Inc expected to post a loss of 58 cents a share - Earnings Preview

Voyager Therapeutics

04/11/2023 03:02

* Voyager Therapeutics Inc  VYGR.OQ   VYGR.O  is expected
to show
a fall in quarterly revenue when it reports  results 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 92.9% decrease in revenue to $2.908 million from $41.09
million a year ago, according to the mean estimate from 7
analysts, based on LSEG data. 
    * ​Refinitiv's mean analyst estimate for Voyager
Therapeutics Inc
is for a loss of 58 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Voyager
Therapeutics Inc is $14.5​, above​ its last closing price
of $6.71. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2023  -0.57       -0.57      -0.51     Beat    10.3
 Mar. 31 2023  1.00        0.77       2.94      Beat    281
 Dec. 31 2022  -0.54       -0.55      -0.61     Missed  -11.5​
 Sep. 30 2022  -0.31       -0.32      0.45      Beat    241.9
 ​​Jun.        -0.48       -0.32      -0.50     Missed  -57.5
 30 2022                                                
 Mar. 31 2022  -0.25       -0.34      -0.56     Missed  -62.7​
 Dec. 31 2021  -0.71       -0.32      0.15      Beat    147.4
 Sep. 30 2021  -0.74       -0.73      -0.67     Beat    7.9
 This summary was machine generated November 4 at 03:02 GMT.  All
figures in US dollars  unless otherwise stated